miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer

Francesco Palma(Percuros (Netherlands)), Cristina Quintavalle(Institute for Experimental Endocrinology and Oncology)
Cancer Gene Therapy
September 18, 2020
Cited by 23


Related Papers